Residual Effect of Sodium Glucose Cotransporter 2 Inhibitor, Tofogliflozin, on Body Weight After Washout in Japanese Men With Type 2 Diabetes

BACKGROUND: We investigated the potential mechanism underlying body weight reduction by the sodium glucose cotransporter 2 (SGLT2) inhibitor, tofogliflozin, during treatment and after subsequent washout. METHODS: Ten Japanese men with type 2 diabetes (average age: 66.3 years) were orally administere...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakuda, Hirokazu, Kobayashi, Junji, Sakurai, Masaru, Takekoshi, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306130/
https://www.ncbi.nlm.nih.gov/pubmed/30627276
http://dx.doi.org/10.14740/jocmr3650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306130/
https://www.ncbi.nlm.nih.gov/pubmed/30627276
http://dx.doi.org/10.14740/jocmr3650

Ejemplares similares